Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androgen Replacement in Premature Ovarian Failure
NCT00001951Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Dec 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in primary ovarian insufficiency (POI) comparing Estradiol + Testosterone + Progestin with Estradiol + Placebo + Progestin (2 arms). Primary endpoint: Femoral Neck Bone Mineral Density at 3 years. Started Dec 1999; status: completed.
02
Drugs
testosterone
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT00001951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001951.